Given that the absence of FHL2 facilitates a higher inflammation state and that the BLM-mediated development of lung fibrosis is driven by acute pulmonary inflammation due to the high destruction of lung tissue, it is conceivable that the amount of FHL2 in WT lungs will decrease during lung fibrosis. This evidence concerns the gene FHL2 and inflammatory response.